Claude Maraoui - 17 Jun 2025 Form 4 Insider Report for Journey Medical Corp (DERM)

Role
President & CEO, Director
Signature
/s/ Ramsey Alloush, attorney-in-fact
Issuer symbol
DERM
Transactions as of
17 Jun 2025
Net transactions value
$0
Form type
4
Filing time
20 Jun 2025, 16:05:13 UTC
Previous filing
05 May 2025
Next filing
26 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Maraoui Claude President & CEO, Director C/O JOURNEY MEDICAL CORPORATION, 9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE /s/ Ramsey Alloush, attorney-in-fact 20 Jun 2025 0001893880

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DERM Common Stock, $0.0001 par value Award $0 +49,277 +2.1% $0.000000 2,397,590 17 Jun 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DERM Stock Option (Right to Buy) Award $0 +82,915 $0.000000 82,915 17 Jun 2025 Common Stock, $0.0001 par value 82,915 $6.31 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 17, 2025, the reporting person was granted 49,277 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 16,426 shares on January 1, 2026, 16,426 shares on January 1, 2027 and 16,425 shares on January 1, 2028.
F2 Includes restricted stock units, which vest over various time periods.
F3 On June 17, 2025, the reporting person was granted 82,915 stock options pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 27,638 shares on January 1, 2026, 27,638 shares on January 1, 2027 and 27,639 shares on January 1, 2028.